Lon­za en­ters the ex­o­some ther­a­py space with ac­qui­si­tion of still-new Co­di­ak site

In an­tic­i­pa­tion of tack­ling the man­u­fac­tur­ing prob­lems that come with ex­o­some ther­a­peu­tics head on, Co­di­ak Bio­Sciences built a 12,000-square-foot man­u­fac­tur­ing site in Lex­ing­ton, MA. Tues­day, it an­nounced that it will hand over the reins to a pow­er­house CD­MO.

Swiss man­u­fac­tur­er Lon­za will ac­quire IP rights and the fa­cil­i­ty from Co­di­ak in ex­change for $65 mil­lion worth of man­u­fac­tur­ing ser­vices, the com­pa­nies said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER